These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 18042830)

  • 1. Painful purinergic receptors.
    Donnelly-Roberts D; McGaraughty S; Shieh CC; Honore P; Jarvis MF
    J Pharmacol Exp Ther; 2008 Feb; 324(2):409-15. PubMed ID: 18042830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinergic actions on neurons that modulate nociception in the rostral ventromedial medulla.
    Selden NR; Carlson JD; Cetas J; Close LN; Heinricher MM
    Neuroscience; 2007 Jun; 146(4):1808-16. PubMed ID: 17481825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats.
    Okada M; Nakagawa T; Minami M; Satoh M
    J Pharmacol Exp Ther; 2002 Oct; 303(1):66-73. PubMed ID: 12235234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2X receptors: targets for novel analgesics?
    Kennedy C
    Neuroscientist; 2005 Aug; 11(4):345-56. PubMed ID: 16061521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of adenosine and P2Y receptors by ATP in human peripheral nerve.
    Lang PM; Tracey DJ; Irnich D; Sippel W; Grafe P
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):449-57. PubMed ID: 12382074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2X receptors and nociception.
    Chizh BA; Illes P
    Pharmacol Rev; 2001 Dec; 53(4):553-68. PubMed ID: 11734618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purines and pain mechanisms: recent developments.
    Liu XJ; Salter MW
    Curr Opin Investig Drugs; 2005 Jan; 6(1):65-75. PubMed ID: 15675605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive properties of a non-nucleotide P2X3/P2X2/3 receptor antagonist.
    McGaraughty S; Jarvis MF
    Drug News Perspect; 2005 Oct; 18(8):501-7. PubMed ID: 16391720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2X receptors-mediated cytosolic phospholipase A2 activation in primary afferent sensory neurons contributes to neuropathic pain.
    Tsuda M; Hasegawa S; Inoue K
    J Neurochem; 2007 Nov; 103(4):1408-16. PubMed ID: 17725579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells.
    Tomé AR; Castro E; Santos RM; Rosário LM
    BMC Neurosci; 2007 Jun; 8():39. PubMed ID: 17570839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of peripheral purinoceptors in sympathetic modulation of capsaicin-induced sensitization of primary afferent fibers.
    Ren Y; Zou X; Fang L; Lin Q
    J Neurophysiol; 2006 Nov; 96(5):2207-16. PubMed ID: 16885522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2X receptors and modulation of pain transmission: focus on effects of drugs and compounds used in traditional Chinese medicine.
    Liang S; Xu C; Li G; Gao Y
    Neurochem Int; 2010 Dec; 57(7):705-12. PubMed ID: 20863868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene polymorphisms in ATP (purinergic) receptors and pain sensitivity].
    Ide S; Minami M; Ikeda K
    Masui; 2009 Sep; 58(9):1122-9. PubMed ID: 19764435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer.
    Shabbir M; Ryten M; Thompson C; Mikhailidis D; Burnstock G
    BJU Int; 2008 Feb; 101(3):352-9. PubMed ID: 18005209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory purinergic P2 receptor characterisation in rat distal colon.
    Van Crombruggen K; Van Nassauw L; Timmermans JP; Lefebvre RA
    Neuropharmacology; 2007 Aug; 53(2):257-71. PubMed ID: 17612577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of disease: role of purinergic signaling in the pathophysiology of bladder dysfunction.
    Ruggieri MR
    Nat Clin Pract Urol; 2006 Apr; 3(4):206-15. PubMed ID: 16607369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purinergic P2 receptors as targets for novel analgesics.
    Burnstock G
    Pharmacol Ther; 2006 Jun; 110(3):433-54. PubMed ID: 16226312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses.
    Köles L; Furst S; Illes P
    Drug News Perspect; 2005 Mar; 18(2):85-101. PubMed ID: 15883618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve growth factor-stimulated neuronal differentiation induces changes in P2 receptor expression and nucleotide-stimulated catecholamine release.
    Arthur DB; Taupenot L; Insel PA
    J Neurochem; 2007 Mar; 100(5):1257-64. PubMed ID: 17241236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple P2X and P2Y receptor subtypes in mouse J774, spleen and peritoneal macrophages.
    Coutinho-Silva R; Ojcius DM; Górecki DC; Persechini PM; Bisaggio RC; Mendes AN; Marks J; Burnstock G; Dunn PM
    Biochem Pharmacol; 2005 Feb; 69(4):641-55. PubMed ID: 15670583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.